Eligibility for Cisplatin Therapy in Patients with MIBC

Dr Terence Friedlander defines cisplatin eligibility in patients with MIBC and discusses how many patients receive neoadjuvant cisplatin and the treatment approaches if a patient is ineligible.

Related Videos
John Allan, MD, an expert on chronic lymphocytic leukemia
Related Content